Keywords: ایرباسارتان; Irbesartan; Degradation products; HRMS; NMR; 15N HSQC; 15N HMBC;
مقالات ISI ایرباسارتان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایرباسارتان; Irbesartan; Amorphous nanoparticles; Dissolution rate; High-gravity; Liquid antisolvent precipitation;
Keywords: ایرباسارتان; fast dissolving tablets; irbesartan; jackfruit seeds; superdisintegrants;
Keywords: ایرباسارتان; atorvastatin; combination; hyperlipidemia; hypertension; irbesartan;
Keywords: ایرباسارتان; Hydrochlorothiazide; Irbesartan; Candesartan; Spectrophotometry; MCR; CRACLS;
Keywords: ایرباسارتان; Irbesartan; Amlodipine besylate; HPTLC; Stress degradation; Validation
Keywords: ایرباسارتان; Irbesartan; Hydrochlorothiazide; Ratio subtraction; Constant multiplication; Ratio difference and constant center;
Keywords: ایرباسارتان; Diabetic nephropathy; Angiotensin receptor antagonist; Irbesartan; ER stress; Inflammation;
Keywords: ایرباسارتان; Adult; albuminuria; aldosterone; angiotensin II; angiotensin II receptor blocker; anuria; double-blinded; glomerular filtration rate (GFR); GFR decline; hemodialysis (HD); investigator-initiated; irbesartan; multicenter study; placebo; preservation of res
Keywords: ایرباسارتان; Irbesartan; Surface solid dispersion; Super disintegrants;
Chronomodulated drug delivery system of Irbesartan: Formulation and development using Desing of Experiment (DoE)
Keywords: ایرباسارتان; Irbesartan; Pulsatile; HPMC K4M; Eudragit RLPO; Lag time;
Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy
Keywords: ایرباسارتان; ABP; arterial blood pressure; ACE; angiotensin converting enzyme; AGEs; advanced glycation end products; ARB; angiotensin receptor blocker; BUN; blood urea nitrogen; Cr Cl; creatinine clearance; DN; diabetic nephropathy; GSH-Px; glutathione peroxidase; Hb
Targeting the proinflammatory cytokines, oxidative stress, apoptosis and TGF-β1/STAT-3 signaling by irbesartan to ameliorate doxorubicin-induced hepatotoxicity
Keywords: ایرباسارتان; Inflammation; Oxidative stress; Irbesartan; Doxorubicin; Hepatotoxicity; Mice;
Pretreatment with an angiotensin II receptor blocker abolished ameliorating actions of adipose-derived stem cell sheets on cardiac dysfunction and remodeling after myocardial infarction
Keywords: ایرباسارتان; Adipose-derived stem cell sheet; Myocardial infarction; Angiotensin II; Irbesartan; VEGF; ANP; atrial natriuretic peptide; ARB; angiotensin receptor blocker; ASC; adipose-derived stem cell; AT1(2)R; angiotensin II receptor type 1(2); CRT; cardiac resynchr
Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway
Keywords: ایرباسارتان; Irbesartan; AGEs; Diabetes mellitus; Osteoporosis;
Potential of angiotensin II receptor blockers in the treatment of diabetic retinopathy
Keywords: ایرباسارتان; Angiotensin II; Candesartan; Irbesartan; Valsartan; Telmisartan;
Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET)
Keywords: ایرباسارتان; endothelin receptor antagonist; focal segmental glomerulosclerosis; irbesartan; nephrotic syndrome; proteinuria; sparsentan;
Electrochemical investigation of Irbesartan drug molecules as an inhibitor of mild steel corrosion in 1Â M HCl and 0.5Â M H2SO4 solutions
Keywords: ایرباسارتان; Irbesartan; OCP; NMR; Mild steel; Polarization; Inhibitors;
Exploring the interactions of irbesartan and irbesartan-2-hydroxypropyl-β-cyclodextrin complex with model membranes
Keywords: ایرباسارتان; Irbesartan; DPPC; HP-β-CD; Molecular dynamics; Small angle X-ray scattering;
Determination of azide impurity in sartans using reversed-phase HPLC with UV detection
Keywords: ایرباسارتان; Azide; HPLC-UV; Sartans; Irbesartan; Candesartan; Valsartan; Genotoxic impurity;
Effect and mechanism of Irbesartan on occurrence of ventricular arrhythmias in rats with myocardial ischemia through connexin43 (cx43)
Keywords: ایرباسارتان; Irbesartan; Myocardial ischemia; Cx43; Connexin; Arrhythmias;
Fabrication of electrospun nanofibres of BCS II drug for enhanced dissolution and permeation across skin
Keywords: ایرباسارتان; Irbesartan; Polyvinyl pyrrolidone; Nanofibres; Skin permeation; Electrospinning; Transdermal drug delivery
The use of supercritical anti-solvent (SAS) technique for preparation of Irbesartan-Pluronic® F-127 nanoparticles to improve the drug dissolution
Keywords: ایرباسارتان; Irbesartan; Supercritical anti-solvent; Solid dispersion; Dissolution improvement
RP-HPLC Stability-indicating Method for Estimation of Irbesartan and Hydrochlorothiazide in Bulk and Pharmaceutical Dosage Form
Keywords: ایرباسارتان; Irbesartan; Hydrochlorothiazide; High performance liquid chromatographic; Validation Methods; Stability; Degradation
Irbesartan attenuates production of high-mobility group box 1 in response to lipopolysaccharide via downregulation of interferon-β production
Keywords: ایرباسارتان; High-mobility group box 1; Interferon-β; Irbesartan; Lipopolysaccharide; Nitric oxide
Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity
Keywords: ایرباسارتان; Irbesartan; Hepatitis B virus; Viral entry inhibitor; NTCP; HepG2;
New ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of irbesartan in human plasma
Keywords: ایرباسارتان; high throughput analysis; irbesartan; pharmacokinetic; tandem mass spectrometry toxicokinetic; ultra-performance liquid chromatography
Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model
Keywords: ایرباسارتان; Diabetic cardiomyopathy; Irbesartan; Protein kinase D; Endoplasmic reticulum stressARB, angiotensin II receptor blocker; Bax, bcl2-associated X protein; Bcl-2, b-cell lymphoma/leukemia-2; CAMK, calcium/calmodulin-dependent protein kinase; DCM, diabetic ca
Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by ultra high performance liquid chromatography tandem mass spectrometry and its application to a bioequivalence study
Keywords: ایرباسارتان; Irbesartan; Hydrochlorothiazide; U-HPLC–MS/MS; Human plasma; Bioequivalence
Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats
Keywords: ایرباسارتان; Fructose-induced metabolic syndrome; Montelukast; Irbesartan
Observational study on patients’ compliance with Irbesartan in essential hypertension “I Comply”
Keywords: ایرباسارتان; Hypertension; Irbesartan; Compliance; Angiotensin; Antihypertensive
Low level drug product API form analysis – Avalide tablet NIR quantitative method development and robustness challenges
Keywords: ایرباسارتان; Irbesartan; Polymorph; Spectroscopy; ssNMR; PLS
Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: Influence of pH and excipients
Keywords: ایرباسارتان; Irbesartan; γ-Cyclodextrin; Solubilization; Complexation; pH; Excipient
A Cost-Effectiveness Analysis between Amlodipine and Angiotensin II Receptor Blockers in Stroke and Myocardial Infarction Prevention among Hypertension Patients in China
Keywords: ایرباسارتان; amlodipine; angiotensin II receptor blockers; China; cost-effectiveness; hypertension; irbesartan;
Mesoporous silica based macromolecules for dissolution enhancement of Irbesartan drug using pre-adjusted pH method
Keywords: ایرباسارتان; Irbesartan; Silica-based microcapsules; Dissolution enhancement; Pre-adjusted pH method; Solid dispersion
Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats
Keywords: ایرباسارتان; Cardiac fibrosis; Diabetes; Irbesartan; Endothelial-to-mesenchymal transition; Rats; Human aortic endothelial cells
Irbesartan administration therapeutically influences circulating endothelial progenitor cell and microparticle mobilization by involvement of pro-inflammatory cytokines
Keywords: ایرباسارتان; Irbesartan; Endothelial progenitor cells; Microparticles; Atherosclerosis
Quantitative estimation of irbesartan in two different matrices and its application to human and dog bioavailability studies using LC–MS/MS
Keywords: ایرباسارتان; Irbesartan; Pharmacokinetics; Solid phase extraction; LC–MS/MS
Irbesartan drug formulated as nanocomposite particles for the enhancement of the dissolution rate
Keywords: ایرباسارتان; Irbesartan; Composite particles; Stabilizer; Dissolution rate;
Inulin and poly(acrylic acid) grafted inulin for dissolution enhancement and preliminary controlled release of poorly water-soluble Irbesartan drug
Keywords: ایرباسارتان; Inulin; Poly(acrylic acid) grafted inulin; Poorly water-soluble drug; Control of drug release; Irbesartan
Electrochemical determination of antihypertensive drug irbesartan in pharmaceuticals
Keywords: ایرباسارتان; Irbesartan; Voltammetry; Method development; Surfactants; Quantitative analysis;
Quantitation of irbesartan and major proteins in human plasma by mass spectrometry with time-of-flight analyzer
Keywords: ایرباسارتان; MALDI-TOF; Irbesartan; Angiotensin II receptor blocker; Chemical analogues; Nanoliquid chromatography
Retrospective Analysis of Real-World Efficacy of Angiotensin Receptor Blockers Versus Other Classes of Antihypertensive Agents in Blood Pressure Management
Keywords: ایرباسارتان; antihypertensive; ARB; cardiovascular; hypertension; irbesartan; persistence
A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide
Keywords: ایرباسارتان; HPTLC; hydrochlorothiazide; irbesartan; stability-indicating; stress degradation;
Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectrometry: Application to bioequivalence studies
Keywords: ایرباسارتان; Irbesartan; Hydrochlorothiazide; Simultaneous; LC–MS/MS; Bioequivalence
Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells
Keywords: ایرباسارتان; Irbesartan; Glucose transporter isotype 4; C2C12 cell; L6-GLUT4myc cell
Identification and characterization of degradation products of irbesartan using LC–MS/TOF, MSn, on-line H/D exchange and LC–NMR
Keywords: ایرباسارتان; Irbesartan; Degradation products; LC–MS/TOF; On-line H/D exchange; LC–NMR
Original loading and Suzuki conditions for the solid-phase synthesis of biphenyltetrazoles. Application to the first solid-phase synthesis of irbesartan
Keywords: ایرباسارتان; Tetrazoles; Solid-phase; Irbesartan; Zinc triflate;
Liquid chromatographic determination of irbesartan in human plasma
Keywords: ایرباسارتان; Irbesartan; Fluorescence detection; Liquid–liquid extraction
Extractive-spectrophotometric determination of disopyramide and irbesartan in their pharmaceutical formulation
Keywords: ایرباسارتان; Disopyramide; Irbesartan; Bromocresol green; Bromothymol blue; Picric acid; Cobalt thiocyanate; Molybdenum(V) thiocyanate